This CDC cooperative agreement grant is designed to support non-research initiatives focused on enhancing healthcare for individuals with Duchenne Muscular Dystrophy (DMD). The primary purpose is to develop a comprehensive plan for evaluating the current delivery of health care treatments and services. This evaluation will ascertain whether these services align with the specific recommendations outlined in the DMD Care Considerations. By funding the development of such an evaluative framework, the grant aims to ensure that people living with DMD receive care that consistently meets established best practice guidelines, ultimately improving the quality and consistency of healthcare provision for this population.
Opportunity ID: 162033
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-DD12-1208 |
| Funding Opportunity Title: | Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 93.184 — Disabilities Prevention |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 05, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jun 04, 2012 |
| Current Closing Date for Applications: | Jun 04, 2012 |
| Archive Date: | Jul 04, 2012 |
| Estimated Total Program Funding: | $150,000 |
| Award Ceiling: | $150,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention |
| Description: | The purpose of this program is to provide support through a CDC cooperative agreement for non-research activities to develop a plan for evaluating whether health care treatments and services for people who have Duchenne muscular dystrophy are currently being delivered according to recommendations outlined in the DMD Care Considerations |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Technical Information and Management Section (TIMS) Phone 770-488-2700 Email:pgotim@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 162033 Full Announcement-1 -> dd12-1208 foa final 4.5.12.pdf
Packages
| Agency Contact Information: | Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Technical Information and Management Section (TIMS) Phone 770-488-2700 Email: pgotim@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.184 | NCBDDD-NR | NCBDDD-NR | PKG00114210 | Apr 05, 2012 | Jun 04, 2012 | View |
Package 1
Mandatory forms
162033 SF424-2.0.pdf
162033 SF424A-1.0.pdf
162033 HHS_CheckList-1.1.pdf
162033 Project-1.1.pdf
162033 Budget-1.1.pdf
Optional forms
162033 Other-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
